A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication
Open Access
- 22 December 2005
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 23 (2), 281-287
- https://doi.org/10.1111/j.1365-2036.2006.02756.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication TreatmentsHelicobacter, 2005
- A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication coursesAlimentary Pharmacology & Therapeutics, 2005
- A 10-day levofloxacin-based therapy in patients with resistant infection: A controlled trialClinical Gastroenterology and Hepatology, 2004
- Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicatingHelicobacter pyloriWorld Journal of Gastroenterology, 2004
- Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary studyDigestive and Liver Disease, 2003
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 1999
- Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practiceAlimentary Pharmacology & Therapeutics, 1999
- Guidelines for the management of Helicobacter pylori infectionAmerican Journal of Gastroenterology, 1998
- Factors influencing the eradication of Helicobacter pylori with triple therapyGastroenterology, 1992